Pharmaceutical Fronts (Sep 2022)

Selective Nitro Reduction of Ester Substituted Nitroarenes by NaBH4-FeCl2

  • Zi-Hong Zhou,
  • Yong-Bo Xu,
  • Shu-Ming Wu,
  • Wei-Jian Ling,
  • Lei Zhang,
  • Zhong-Qing Wang

DOI
https://doi.org/10.1055/s-0042-1756457
Journal volume & issue
Vol. 04, no. 03
pp. e151 – e156

Abstract

Read online

Abstract This work aimed to explore a novel protocol for selective reduction of the nitro group on the aromatic ring while remaining the ester group unaffected. In this study, NaBH4-FeCl2 was disclosed as a key reductant in the process. NaBH4-FeCl2-mediated reduction showed high chemoselectivity, gave the desired products in magnificent yield (up to 96%), and was applied to synthesize a key intermediate of vilazodone (an antidepressant drug) on a hectogram scale in a total yield of 81% (two steps). The protocol is practical, and capable of synthesis of a range of aromatic amines, especially those with ester substituted in the ring.

Keywords